> The University of Leicester corralled a £2.4 million ($3.6 million) research funding grant for its work on gene expression that could lead to anti-cancer drugs using protein complexes as drug targets. Report
> pSivida ($PSDV) began a Phase III pivotal trial, the first of two, for its micro-insert designed to treat chronic, non-infectious uveitis affecting the posterior segment of the eye. Release
> Researchers at RMIT in Australia have created nanoparticles called yoctowells that allow for better encapsulation of drugs and controlled release. Story
> Oxford professor Constantin Coussios is looking into the potential of ultrasound as a drug-delivery tool, most particularly for people with vertebrae problems. Article